The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery contract to We Pharma, Inc., doing business as WEP Clinical, with a potential value of $9.5 million. The contract has no set-aside designation and is a single-award arrangement to provide currently marketed drug products for FDA research studies from September 2020 through September 2025. Under this contract, WEP Clinical has received multiple firm fixed price delivery orders to supply pharmaceuticals to the FDA's offices in Silver Spring, Maryland; St. Louis, Missouri; and Morrisville, North Carolina. Delivery orders range in value from $100,000 to $500,000 with periods of performance from December 2021 through January 2023. The drug products will support the FDA's clinical, regulatory science, research, and compliance activities, including studies related to the Generic Drug User Fee Amendments program. The original solicitation sought sources of currently marketed drug products for FDA research studies, with responses due in August 2020. WEP Clinical was awarded the indefinite delivery contract and subsequent delivery orders to provide the requested pharmaceuticals.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| P00002 | Other Administrative Action | $0 | 5/16/22 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 12/1/21 | |
| Not listed | Not listed | $0 | 9/29/20 |
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order 75F40120D00032-75F40121F19005 | We Pharma, Inc. | $477.9k | 9/11/21 | 1/31/23 | 3/21/24 | |
Delivery Order 75F40120D00032-75F40122F19006 | We Pharma, Inc. | $100.0k | 12/2/21 | 12/5/22 | 9/1/22 | |
Delivery Order 75F40120D00032-75F40123F19007 | We Pharma, Inc. | $182.6k | 12/23/22 | 11/30/24 | 5/17/24 | |
Delivery Order 75F40120D00032-75F40120F19004 | We Pharma, Inc. | $169.9k | 9/30/20 | 9/29/21 | 2/9/23 | |
Delivery Order 75F40120D00032-75F40120F19002 | We Pharma, Inc. | $246.8k | 9/30/20 | 9/29/21 | 4/26/22 |
Name | Description | Solicitation Number | Federal Agency | Type | Posted Date (Click to sort descending) |
|---|---|---|---|---|---|
To provide brand name and/or generic pharmaceuticals to include small molecule and peptide therapeutics, drug-device combination products, and contrast agents. | FDASOL1222072 | Department of Health and Human Services Food and Drug Administration | Solicitation 1/1 | 8/4/20, 11:59 AM |